Insilico Medicine Presents 4 Generative AI-Designed Anti-Cancer Drugs at AACR (VIDEO)

InSilico Medicine

Caption

Insilico's anti-cancer assets include a USP1 inhibitor, MAT2A inhibitor, DGKA inhibitor, and CDK12 inhibitor.

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.